Yasushi Akahori

Tsu, 5148507, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Introducing arginine residues into scFv in CAR-T cells shows promising antitumor effects.

Introducing arginine residues into scFv in CAR-T cells shows promising antitumor effects.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 16, 2025

Correction: Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding.

Correction: Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding.

Journal: The Journal of biological chemistry
Published: December 10, 2024

MAGE-A4 pMHC-targeted CAR-T cells exploiting TCR machinery exhibit significantly improved in vivo function while retaining antigen specificity.

MAGE-A4 pMHC-targeted CAR-T cells exploiting TCR machinery exhibit significantly improved in vivo function while retaining antigen specificity.

Journal: Journal for immunotherapy of cancer
Published: October 27, 2024

Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding.

Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding.

Journal: The Journal of biological chemistry
Published: July 26, 2024

TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors.

TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors.

Journal: Biomedicines
Published: September 29, 2023

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4.

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4.

Journal: International journal of molecular sciences
Published: August 04, 2023

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy.

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy.

Journal: International journal of molecular sciences
Published: May 21, 2023

Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4p230-239/HLA-A∗02:01 complex.

Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4p230-239/HLA-A∗02:01 complex.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 25, 2023

αβ-T cell receptor transduction gives superior mitochondrial function to γδ-T cells with promising persistence.

αβ-T cell receptor transduction gives superior mitochondrial function to γδ-T cells with promising persistence.

Journal: iScience
Published: March 31, 2023

Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.

Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.

Journal: Blood
Published: August 24, 2017

Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types.

Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types.

Journal: PloS one
Published: January 10, 2016

Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.

Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.

Journal: Gene therapy
Published: June 17, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026